Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-13 12:42 pm Sale | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Flynn James E | 0 0% | -1,128,822 (Position Closed) | View |
| 2020-02-13 12:41 pm Sale | 13G | DIPLOMAT PHARMACY INC DPLO | Flynn James E | 0 0% | -6,899,297 (Position Closed) | View |
| 2020-02-13 12:39 pm Sale | 13G | AXOGEN, INC. AXGN | Flynn James E | 0 0% | -2,469,501 (Position Closed) | View |
| 2020-02-13 12:38 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Flynn James E | 0 0% | -2,722,241 (Position Closed) | View |
| 2020-02-13 12:36 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | Flynn James E | 0 0% | -2,848,374 (Position Closed) | View |
| 2020-02-13 12:35 pm Unchanged | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 3,448,912 15% | 0 (Unchanged) | View |
| 2020-02-13 12:34 pm Sale | 13G | EHEALTH, INC. EHTH | Flynn James E | 204,000 0.88% | -872,402 (-81.05%) | View |
| 2020-02-13 12:33 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Flynn James E | 6,375,143 4.14% | -535,646 (-7.75%) | View |
| 2020-02-13 12:31 pm Sale | 13G | AERIE PHARMACEUTICALS INC AERI | Flynn James E | 1,772,255 3.83% | -1,160,732 (-39.58%) | View |
| 2020-02-13 12:30 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Flynn James E | 4,289,291 9.76% | 2,540,286 (+145.24%) | View |
| 2020-02-13 12:28 pm Unchanged | 13G | NEURONETICS INC STIM | Flynn James E | 1,075,000 5.77% | 0 (Unchanged) | View |
| 2020-02-13 12:26 pm Sale | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Flynn James E | 2,378,000 5.06% | -113,881 (-4.57%) | View |
| 2020-02-13 12:24 pm Sale | 13G | CABALETTA BIO INC CABA | Flynn James E | 1,628,504 6.78% | -2 (-0.00%) | View |
| 2020-02-13 12:23 pm Purchase | 13G | ARDELYX INC ARDX | Flynn James E | 7,004,253 8.45% | 3,774,037 (+116.84%) | View |
| 2020-02-10 1:22 pm Purchase | 13G | SCHRODINGER INC SDGR | Flynn James E | 1,596,167 3.31% | 1,596,167 (New Position) | View |
| 2020-02-03 1:28 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | Flynn James E | 778,789 2.27% | 778,789 (New Position) | View |
| 2020-01-31 4:19 pm Sale | 13D | HOMOLOGY MEDICINES INC FIXX | Flynn James E | 4,087,305 9.28% | -1,158,333 (-22.08%) | View |
| 2020-01-24 5:24 pm Sale | 13D | ADAPTHEALTH CORP AHCO | Flynn James E | 19,674,202 42.68% | -2,394,964 (-10.85%) | View |
| 2020-01-23 10:51 am Purchase | 13G | BEYOND AIR INC XAIR | Flynn James E | 856,863 5.78% | 856,863 (New Position) | View |
| 2020-01-23 10:50 am Purchase | 13G | ALIMERA SCIENCES INC ALIM | Flynn James E | 676,667 9.98% | 676,667 (New Position) | View |